We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

176 hedge funds and large institutions have $1.91B invested in Prestige Consumer Healthcare in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 54 increasing their positions, 77 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 16

8% more capital invested

Capital invested by funds: $1.77B → $1.91B (+$146M)

1% more funds holding

Funds holding: 174176 (+2)

0.56% more ownership

Funds ownership: 105.22%105.78% (+0.56%)

30% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 77

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

100% less call options, than puts

Call options by funds: $3K | Put options by funds: $3.87M

Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
4.69%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
21
Increased
54
Reduced
77
Closed
16
Calls
$3K
Puts
$3.87M
Net Calls
-$3.87M
Net Calls Change
-$942K
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
126
Martingale Asset Management
Massachusetts
$406K -$520K -15,656 -57%
OAM
127
Oxford Asset Management
United Kingdom
$394K -$832K -25,085 -69%
Citadel Advisors
128
Citadel Advisors
Florida
$383K +$366K +11,038 New
Credit Agricole
129
Credit Agricole
France
$374K -$293K -8,822 -45%
PI
130
Placemark Investments
Illinois
$350K +$31.4K +946 +10%
PA
131
Profund Advisors
Maryland
$337K +$68.3K +2,058 +27%
TI
132
Trexquant Investment
Connecticut
$322K +$309K +9,300 New
GCM
133
Gator Capital Management
Florida
$318K +$304K +9,161 New
Tudor Investment Corp
134
Tudor Investment Corp
Connecticut
$315K -$94.3K -2,842 -24%
OA
135
OFI Advisors
Pennsylvania
$299K -$8.99K -271 -3%
Barclays
136
Barclays
United Kingdom
$280K +$213K +6,409 +350%
GC
137
Guggenheim Capital
Illinois
$277K -$856K -25,795 -76%
SB
138
Suntrust Banks
Georgia
$272K +$35K +1,055 +15%
Legal & General Group
139
Legal & General Group
United Kingdom
$270K -$5.67K -171 -2%
PNC Financial Services Group
140
PNC Financial Services Group
Pennsylvania
$256K
GAM
141
Gotham Asset Management
New York
$234K -$13.7M -413,642 -98%
Nisa Investment Advisors
142
Nisa Investment Advisors
Missouri
$226K
Stifel Financial
143
Stifel Financial
Missouri
$218K +$209K +6,293 New
Royal Bank of Canada
144
Royal Bank of Canada
Ontario, Canada
$213K +$39.5K +1,191 +24%
AG
145
Aperio Group
California
$208K +$199K +6,004 New
US Bancorp
146
US Bancorp
Minnesota
$134K +$7.1K +214 +6%
KBC Group
147
KBC Group
Belgium
$115K +$110K +3,324 New
TRCT
148
Tower Research Capital (TRC)
New York
$98K -$10.1K -304 -10%
Canada Life
149
Canada Life
Manitoba, Canada
$96K
DADC
150
D.A. Davidson & Co
Montana
$95K +$13.7K +413 +18%

PBH Hedge Fund Activity: Q4 2014 in Review

176 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2014, worth a combined $1.91B — up 8.2% from $1.77B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new PBH positions and 16 closed out — a net gain of 5 holders — while 54 added to existing stakes and 77 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $40.4M. The largest seller was Keeley Asset Management, exiting entirely with an estimated $27.3M sold.

  • 176 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2014, up from 174 in Q3 2014.
  • Funds reported $1.91B of Prestige Consumer Healthcare stock for Q4 2014, up 8.2% quarter-over-quarter.
  • 21 funds opened new Prestige Consumer Healthcare positions in Q4 2014 and 16 closed out, a net change of +5 holders.
  • The largest Prestige Consumer Healthcare buyer in Q4 2014 was Fidelity Investments, an estimated $40.4M added.
  • The largest Prestige Consumer Healthcare seller in Q4 2014 was Keeley Asset Management, an estimated $27.3M sold.

Based on aggregated 13F filings for Q4 2014.